181 related articles for article (PubMed ID: 38289119)
1. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
[TBL] [Abstract][Full Text] [Related]
2. Polypyrimidine tract-binding protein (PTB) and PTB-associated splicing factor in CVB3 infection: an ITAF for an ITAF.
Dave P; George B; Sharma DK; Das S
Nucleic Acids Res; 2017 Sep; 45(15):9068-9084. PubMed ID: 28633417
[TBL] [Abstract][Full Text] [Related]
3. Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype.
Phillips L; Tapprich WE
J Virol; 2023 May; 97(5):e0044823. PubMed ID: 37074194
[TBL] [Abstract][Full Text] [Related]
4. Cellular Protein HuR Regulates the Switching of Genomic RNA Templates for Differential Functions during the Coxsackievirus B3 Life Cycle.
George B; Dave P; Rani P; Behera P; Das S
J Virol; 2021 Oct; 95(21):e0091521. PubMed ID: 34406862
[TBL] [Abstract][Full Text] [Related]
5. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
7. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148.
Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D
Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794
[TBL] [Abstract][Full Text] [Related]
9. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.
Ullmer W; Semler BL
mBio; 2018 Sep; 9(5):. PubMed ID: 30181254
[TBL] [Abstract][Full Text] [Related]
10. The mammalian host protein DAP5 facilitates the initial round of translation of Coxsackievirus B3 RNA.
Dave P; George B; Raheja H; Rani P; Behera P; Das S
J Biol Chem; 2019 Oct; 294(42):15386-15394. PubMed ID: 31455634
[TBL] [Abstract][Full Text] [Related]
11. La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA.
Ray PS; Das S
Nucleic Acids Res; 2002 Oct; 30(20):4500-8. PubMed ID: 12384597
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication
Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R
Front Immunol; 2020; 11():603437. PubMed ID: 33519812
[TBL] [Abstract][Full Text] [Related]
13. Polypyrimidine tract-binding protein interacts with coxsackievirus B3 RNA and influences its translation.
Verma B; Bhattacharyya S; Das S
J Gen Virol; 2010 May; 91(Pt 5):1245-55. PubMed ID: 20071487
[TBL] [Abstract][Full Text] [Related]
14. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.
Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014
[TBL] [Abstract][Full Text] [Related]
15. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity.
Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J
Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333
[TBL] [Abstract][Full Text] [Related]
16. Poly(rC) binding protein 1 benefits coxsackievirus B3 infection via suppressing the translation of p62/SQSTM1.
He HY; You Z; Ouyang T; Zhao G; Chen LJ; Wang Q; Li JY; Ye X; Zhang MH; Yang D; Ge XY; Qiu Y
Virus Res; 2022 Sep; 318():198851. PubMed ID: 35764193
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome.
Wong J; Si X; Angeles A; Zhang J; Shi J; Fung G; Jagdeo J; Wang T; Zhong Z; Jan E; Luo H
FASEB J; 2013 Jul; 27(7):2777-87. PubMed ID: 23572232
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-324-3p Plays A Protective Role Against Coxsackievirus B3-Induced Viral Myocarditis.
Liu T; Tong J; Shao C; Qu J; Wang H; Shi Y; Lin Y; Liu Y; Shao S; Shen H
Virol Sin; 2021 Dec; 36(6):1585-1599. PubMed ID: 34632544
[TBL] [Abstract][Full Text] [Related]
19. Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity.
Sean P; Nguyen JH; Semler BL
Virology; 2009 Jun; 389(1-2):45-58. PubMed ID: 19446305
[TBL] [Abstract][Full Text] [Related]
20. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region.
Wu Y; Yue Y; Xiong S
Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
